Researching for TBI-related news today brought me to an article that was just released hours ago and focused on a topic I previously posted about in 2017: “The DoD has granted $11.3 million to Abbott Laboratories for the development of a mobile device that allows one to determine if they have a traumatic brain injury, anytime and anyplace.”  The portable blood test, which should be administered within 12 hours of potential brain injury, detects certain biomarkers in the blood that indicate a brain injury.  In March 2023, the U.S. Food & Drug Administration finally approved the Abbott’s Alinity i laboratory device for commercial use.  Soon, it appears, this blood test will be available to athletes, soldiers, and others at medical centers throughout the country.